utilities

Tag Archives | Drug trials

Latest Blogrss link

The latest progress towards new dementia treatments

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

At Alzheimer’s Research UK, we’re committed to funding the most innovative grass-roots research and translating promising discoveries into benefits for people with dementia as quickly as possible. At the Alzheimer’s Research UK Conference 2016 in Manchester this week we’ve been hearing about some of the latest emerging research from across the UK. Where are we […]

New Year’s Resolution: Get involved in dementia research

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

It’s that time of year again where we all start to think about what we can do to be better people. I’ve gone for the classics; I’m going to start at the gym, sort my diet out, and sign up to help beat dementia! I know what you’re thinking, “help beat dementia? Not heard of […]

The Alzheimer’s Research UK Drug Discovery Alliance

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

In February 2015 we launched our £30 million Drug Discovery Alliance. The Drug Discovery Alliance is a network of three Institutes at the Universities of Cambridge and Oxford, and University College London. The Alliance is one of the largest coordinated efforts in the world to find new treatments for dementia and today, we’ve announced the […]

Scientist Focus: Dr John Davis

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

Dr John Davis is the new Chief Scientific Officer at the Alzheimer’s Research UK Oxford Drug Discovery Institute. Tell us a bit about your career path After my PhD and a few years as a post-doctoral researcher in London and the United States, I started work at GlaxoSmithKline – a large pharmaceutical company. There, I […]

Tagged with: ,

Dementia researchers are leaving no stone unturned in the hunt for new treatments

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

A major goal of dementia research is to find treatments that will benefit the millions of people around the world living with the condition. At this week’s Alzheimer’s Association International Conference we’ve heard results from a number of clinical trials – research studies designed to test whether potential treatments are safe and effective. Diseases like […]

Dementia Forum 2015 report: a global call to action

Dr Matthew Norton

Today’s headlines feature a new report from the World Innovation Health Summit Dementia Forum 2015, which underlines the need for global action to tackle dementia. The report makes recommendations to help fight dementia – including steps to attract new investment for research – and outlines some of the obstacles that have hampered research so far. […]

Read more

Boosting the search for new dementia treatments

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

When will we have a new treatment for dementia? It’s a question we get asked a lot. And understandably. There’s been a long wait since the last dementia drug was made available to people – over a decade. Today, we launched the Alzheimer’s Research UK Drug Discovery Alliance, a £30m powerhouse of dementia drug discovery […]

Dementia research in 2014: looking back at our proudest achievements

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

This time of year is full of lists. Best album, five ways to use your Christmas turkey leftovers, 10 pictures of cats dressed as reindeer…. Hopefully you’ve got room for one more! 2014 has been a year of huge strides in research and we want to share some of these successes with you. Our researchers […]

The Global Clinical Trials Fund: drugs and dummies

Dr Laura PhippsKirsty MaraisClaire LucasRobin BrisbourneKaty StubbsEd PinchesGlyn Morris

Today marks one year since the G8 Dementia Summit. The last year has been a whirlwind of new investment and exciting initiatives, both from Alzheimer’s Research UK and government, all with one aim: to bring us closer to a treatment for dementia. But we mustn’t lose momentum. Today, we are pleased to announce our newest […]